Until recently, the process of SV discovery in disease genes like BRCA1 and BRCA2 required gene-specific probes to amplify and quantify the genomic DNA structure and amount, which made it difficult to identify new genes contributing to breast cancer risk though mechanisms such as SV. The gene discussed is BRCA2; the disease is breast cancer.